These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30066876)

  • 81. Lipoic acid a multi-level molecular inhibitor of tumorigenesis.
    Farhat D; Lincet H
    Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188317. PubMed ID: 31669587
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fear stress enhanced xenograft pancreatic tumor growth through activating epithelial-mesenchymal transition.
    Li M; Xu H
    Pancreatology; 2019 Mar; 19(2):377-382. PubMed ID: 30733163
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH.
    Zheng M; Guo J; Xu J; Yang K; Tang R; Gu X; Li H; Chen L
    Food Funct; 2019 Jun; 10(6):3386-3395. PubMed ID: 31112178
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Suppression of CD26 inhibits growth and metastasis of pancreatic cancer.
    Ye C; Tian X; Yue G; Yan L; Guan X; Wang S; Hao C
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27718126
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Emodin inhibits the proliferation and invasion of bladder cancer cells via down-regulating Notch1.
    Ma L; Chen K; Jiang K; Deng G; Jiang P; Shao J; Yu Z
    Int J Clin Exp Pathol; 2017; 10(9):9452-9459. PubMed ID: 31966818
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of RNA binding protein QKI on pancreatic cancer ductal epithelial cells and surrounding activation fibroblasts.
    Chu L; Hu Y; Jiang YH; Xu C; Liu WC; Lu ZF
    J Cell Biochem; 2019 Jul; 120(7):11551-11561. PubMed ID: 30968977
    [TBL] [Abstract][Full Text] [Related]  

  • 87. S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer.
    Low RRJ; Fung KY; Gao H; Preaudet A; Dagley LF; Yousef J; Lee B; Emery-Corbin SJ; Nguyen PM; Larsen RH; Kershaw NJ; Burgess AW; Gibbs P; Hollande F; Griffin MDW; Grimmond SM; Putoczki TL
    Cell Death Differ; 2023 May; 30(5):1155-1165. PubMed ID: 36828915
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pachymic Acid Inhibits Growth and Metastatic Potential in Liver Cancer HepG2 and Huh7 Cells.
    Jiang F; Zhu T; Yang C; Chen Y; Fu Z; Jiang L; Liu Y
    Biol Pharm Bull; 2023 Jan; 46(1):35-41. PubMed ID: 36273899
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway.
    Wang Z; Chen H; Chen J; Hong Z; Liao Y; Zhang Q; Tong H
    Cancer Manag Res; 2019; 11():8463-8473. PubMed ID: 31572001
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pancreatic cancer metastasis: are we being pre-EMTed?
    Das S; Batra SK
    Curr Pharm Des; 2015; 21(10):1249-55. PubMed ID: 25506899
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Fentanyl inhibits cell viability in human pancreatic cancer cell line and tumor growth in pancreatic cancer cell-transplanted mice.
    Miao J; Wang L; Chen L; Yang T; Jin L; Lin L
    Int J Clin Exp Med; 2015; 8(10):17684-93. PubMed ID: 26770358
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Promising xenograft animal model recapitulating the features of human pancreatic cancer.
    Miao JX; Wang JY; Li HZ; Guo HR; Dunmall LSC; Zhang ZX; Cheng ZG; Gao DL; Dong JZ; Wang ZD; Wang YH
    World J Gastroenterol; 2020 Aug; 26(32):4802-4816. PubMed ID: 32921958
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Emodin: inhibitory effects on growth in malignant tumors.
    Kapoor S
    Immunopharmacol Immunotoxicol; 2013 Apr; 35(2):307. PubMed ID: 23480347
    [No Abstract]   [Full Text] [Related]  

  • 94. Upregulation of DLC-1 inhibits pancreatic cancer progression: Studies with clinical samples and a pancreatic cancer model.
    Chen B; Xu M; Xu M
    Oncol Lett; 2019 Nov; 18(5):5600-5606. PubMed ID: 31612067
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Screening of MMP-2 Inhibiting Phytoconstituents for the Development of Newer Pancreatic Cancer Treatment Modalities.
    Periyasamy L; Murugantham B; Sundaraj R; Krishnamoorthi S; Muthusami S
    Protein Pept Lett; 2023; 30(4):304-313. PubMed ID: 36779494
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Emodin inhibits HMGB1-induced tumor angiogenesis in human osteosarcoma by regulating SIRT1.
    Qu W; Wang Y; Wu Q; Liu J; Hao D
    Int J Clin Exp Med; 2015; 8(9):15054-64. PubMed ID: 26628989
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A Carabrane-Type Sesquiterpenolide Carabrone from
    Zheng YD; Zhang Y; Ma JY; Sang CY; Yang JL
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144577
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Emodin: A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets.
    Tuli HS; Aggarwal V; Tuorkey M; Aggarwal D; Parashar NC; Varol M; Savla R; Kaur G; Mittal S; Sak K
    Toxicol In Vitro; 2021 Jun; 73():105142. PubMed ID: 33722736
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comments on "Emodin-Conjugated PEGylation of Fe
    Wang X
    Int J Nanomedicine; 2022; 17():1633-1634. PubMed ID: 35418753
    [No Abstract]   [Full Text] [Related]  

  • 100. Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly.
    Wang T; Chen P; Weir S; Baltezor M; Schoenen FJ; Chen Q
    Front Oncol; 2022; 12():870473. PubMed ID: 36276125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.